CPT code 81506 designates a laboratory service that runs seven biochemical assays linked to diabetes and uses an algorithm to integrate assay results with patient data to report a patient risk score. This code captures combined analytic and reporting activity that supports risk stratification for diabetes-related outcomes and clinical decision-making. Nationally, such molecular/algorithmic testing is increasingly relevant as payers and providers seek quantifiable risk measures to guide population health management and personalized care.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find coverage and coding context for how algorithmic laboratory reports are billed, typical sites of service and clinical roles involved, and the practical implications for claims submission and payer review. The publication summarizes common modifiers associated with laboratory and professional components, outlines where to find additional coding guidance, and situates CPT 81506 within broader trends in lab-developed tests and clinical risk modeling.

Content emphasizes billing and policy relevance rather than clinical recommendations, offering a concise reference for billing staff, laboratory directors, and payers evaluating claims for algorithm-driven diabetes biomarker panels.